These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25880497)

  • 1. Applications of Cas9 as an RNA-programmed RNA-binding protein.
    Nelles DA; Fang MY; Aigner S; Yeo GW
    Bioessays; 2015 Jul; 37(7):732-9. PubMed ID: 25880497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation.
    Mahas A; Neal Stewart C; Mahfouz MM
    Biotechnol Adv; 2018; 36(1):295-310. PubMed ID: 29197619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.
    Fujita T; Fujii H
    Int J Mol Sci; 2015 Sep; 16(10):23143-64. PubMed ID: 26404236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems.
    Jiang W; Marraffini LA
    Annu Rev Microbiol; 2015; 69():209-28. PubMed ID: 26209264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
    Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
    Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC; Xie L; Deng W; Guglielmi B; Witkowsky LB; Bosanac L; Zhang ET; El Beheiry M; Masson JB; Dahan M; Liu Z; Doudna JA; Tjian R
    Science; 2015 Nov; 350(6262):823-6. PubMed ID: 26564855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
    Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
    Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable RNA Tracking in Live Cells with CRISPR/Cas9.
    Nelles DA; Fang MY; O'Connell MR; Xu JL; Markmiller SJ; Doudna JA; Yeo GW
    Cell; 2016 Apr; 165(2):488-96. PubMed ID: 26997482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of CRISPR-Cas9 on target identification and validation.
    Moore JD
    Drug Discov Today; 2015 Apr; 20(4):450-7. PubMed ID: 25572406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The applications of CRISPR/Cas system in molecular detection.
    Zhou L; Peng R; Zhang R; Li J
    J Cell Mol Med; 2018 Dec; 22(12):5807-5815. PubMed ID: 30338908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering.
    Nuñez JK; Harrington LB; Doudna JA
    ACS Chem Biol; 2016 Mar; 11(3):681-8. PubMed ID: 26857072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.
    Koo T; Lee J; Kim JS
    Mol Cells; 2015 Jun; 38(6):475-81. PubMed ID: 25985872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.